Ocumetics Technology Corp. OTCFF
Set alert
At close · Oct 29
- YTD
- -37.18%
- 1 year
- -65.72%
- Open
- 0.2851
- Prev close
- 0.27554
- Mkt cap
- 38.24M
- Vol
- 2.65K
- Avg vol
- 4.70K
- EPS
- -0.04
- P/E
- 0.00
More statistics
- Low
- 0.2851
- High
- 0.2851
News
1 day ago thenewswire.com
Ocumetics Announces Changes to Board of Directors; Appoints Sandi Gilbert as Director and Dean Burns as Chairman
CALGARY, Alberta - October 29, 2026 – TheNewswire - Ocumetics Technology Corp. (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) is pleased to announce the appointment of Sandi…
1 month ago thenewswire.com
Ocumetics Provides Summary of Group One Patient Clinical Progress
Key Highlights Ocumetics is developing an accommodating intraocular lens designed to provide a more natural range of vision, potentially addressing an important limitation of conventional intraocular…
1 month ago thenewswire.com
Ocumetics Announces Initiation of Patient Recruitment for Upcoming Group Two Human Clinical Surgeries
Key Highlights Group Two clinical study underway - Patient recruitment has begun in Mexico City, with surgeries targeted for Fall 2026 .
2 months ago thenewswire.com
Ocumetics Completes Manufacturing of Next Generation Solid State Accommodating Intraocular Lenses for Upcoming Group Two First in Human Clinical Surgeries
Key Highlights Next-generation Ocumetics Lenses successfully manufactured and ready for the Company's upcoming Group Two first-in-human clinical surgeries in Mexico City.
2 months ago thenewswire.com
Ocumetics Announces Completion of Third and Final Tranche of Unit Private Placement
Calgary, Alberta – TheNewswire - August 24, 2026 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it has completed the third…
3 months ago thenewswire.com
Ocumetics Announces Completion of Second Tranche of Unit Private Placement
Calgary, Alberta – July 31, 2026 – TheNewswire - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it has completed the second…
3 months ago thenewswire.com
Ocumetics Announces Upsizing of Unit Private Placement
Calgary, Alberta – TheNewswire - July 30, 2026. Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that as a result of strong investor…
3 months ago thenewswire.com
Ocumetics Announces Completion of First Tranche of Unit Private Placement
Calgary, Alberta – TheNewswire - July 29, 2026. Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it has completed the first…
3 months ago thenewswire.com
Ocumetics Announces Corporate and Operational Update as Positive Six-Month Clinical Results Advance Next Phase of First-in-Human Study
Key Highlights Positive six-month results from the Company's First-in-Human ("FIH") study support advancement to Group Two clinical surgeries
3 months ago thenewswire.com
Ocumetics Announces Offering of Units
Calgary, Alberta – TheNewswire - July 7, 2026 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it proposes to complete a…
5 months ago thenewswire.com
Ocumetics Announces Significant Debt Conversion Strengthening Balance Sheet Ahead of Patient Study Milestones
Key Highlights $1.4 million of debenture principal converted to common shares of Ocumetics
5 months ago thenewswire.com
Ocumetics Accelerates Toward Group Two First-In-Human Study with Manufacturing Launch of Optimized Accommodating Lens
Key Highlights Precision molds received for manufacturing of new optimized accommodating intraocular lenses
6 months ago thenewswire.com
Ocumetics Announces Offering of Units
Calgary, Alberta – TheNewswire - April 29, 2026 - Ocumetics Technology Corp. (“ Ocumetics ” or the “ Corporation ”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) announces that it proposes to complete a…
6 months ago thenewswire.com
Ocumetics Reports Improvement in Six Month First-in-Human Results Meaningful Improvements in Patient Quality of Life
Key Highlights Vision performance: Clinical outcomes exceed expectations, with all patients experiencing continuing vision improvements
6 months ago thenewswire.com
Ocumetics Technology Reports Attendance at ASCRS as Successful First-In-Human Trial Continues, No Material Change
Key Highlights No material change: There is no material change in the business affairs of Ocumetics.
7 months ago thenewswire.com
Ocumetics to Showcase First-In-human Results with Industry Leaders & Potential Strategic Partners at ASCRS Annual Meeting
Key Highlights Early First-in-Human clinical results have drawn the attention of industry leaders and several of the largest vision care technology companies in the world.
7 months ago thenewswire.com
Ocumetics Technology Corp. Achieves Breakthrough in Next-Generation Accommodating Intraocular Lens Design
Key Highlights Breakthrough Accommodating Interocular Lens Design: The enhanced lens design introduces several novel concepts that are expected to improve substantially upon the consistency,…
7 months ago thenewswire.com
Ocumetics Announces Issuance of Stock Options
Calgary, Alberta – March 13, 2026 – TheNewswire - Ocumetics Technology Corp. (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO) (the “ Corporation ”) announces that it has issued 500,000 incentive stock options…
8 months ago thenewswire.com
Ocumetics Announces Scientific Advisory Committee to Support Advancing Clinical and Regulatory Strategy
Calgary, Alberta – TheNewswire - February 26, 2026 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic…
8 months ago thenewswire.com
Ocumetics Announces Appointment of Raymond Marks to Board of Directors
Calgary, Alberta – TheNewswire - February 24, 2026 - Ocumetics Technology Corp . (“Ocumetics” or the “Company”) (TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a leader in next generation ophthalmic…